These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35927132)

  • 21. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against
    Pyles GM; Huckaby AB; Gutierrez MdlP; Witt WT; Mateu-Borrás M; Dublin SR; Rocuskie-Marker C; Sesti BN; Peasak K; Bitzer GJ; Rader N; Weaver KL; Boehm DT; Fitzgerald N; Chapman J; Ulicny S; Damron FH; Barbier M
    Infect Immun; 2024 Aug; 92(8):e0027024. PubMed ID: 39023271
    [No Abstract]   [Full Text] [Related]  

  • 23. A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
    Halperin SA; Langley JM; Ye L; MacKinnon-Cameron D; Elsherif M; Allen VM; Smith B; Halperin BA; McNeil SA; Vanderkooi OG; Dwinnell S; Wilson RD; Tapiero B; Boucher M; Le Saux N; Gruslin A; Vaudry W; Chandra S; Dobson S; Money D
    Clin Infect Dis; 2018 Sep; 67(7):1063-1071. PubMed ID: 30010773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
    Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
    Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
    Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
    [No Abstract]   [Full Text] [Related]  

  • 27. Acellular pertussis vaccines for adolescents.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2005 Jun; 24(6 Suppl):S117-26. PubMed ID: 15931139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.
    Cherry JD; Heininger U; Richards DM; Storsaeter J; Gustafsson L; Ljungman M; Hallander HO
    Clin Vaccine Immunol; 2010 May; 17(5):741-7. PubMed ID: 20335431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women.
    Villarreal Pérez JZ; Ramírez Aranda JM; de la O Cavazos M; Zamudio Osuna MJ; Perales Dávila J; Ballesteros Elizondo MR; Gómez Meza MV; García Elizondo FJ; Rodríguez González AM
    Hum Vaccin Immunother; 2017 Jan; 13(1):128-135. PubMed ID: 27686182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis.
    Abu-Raya B; Maertens K; Munoz FM; Zimmermann P; Curtis N; Halperin SA; Rots N; Barug D; Holder B; Kampmann B; Leuridan E; Sadarangani M
    Front Immunol; 2021; 12():689394. PubMed ID: 34305922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model.
    Han SB; Kang KR; Huh DH; Lee HC; Lee SY; Kim JH; Hur JK; Kang JH
    Clin Exp Vaccine Res; 2015 Jan; 4(1):75-82. PubMed ID: 25649262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD; Gornbein J; Heininger U; Stehr K
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model.
    Huh DH; Han SB; Shin HJ; Ahn DH; Choi GS; Kang KR; Kim BR; Kang JH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):732-739. PubMed ID: 28720318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers.
    McAlister SM; van den Biggelaar AHJ; Woodman TL; Hutton H; Thornton RB; Richmond PC
    Vaccine; 2021 Mar; 39(11):1642-1651. PubMed ID: 33589299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP.
    Decker MD; Greenberg DP; Johnson DR; Pool V
    Vaccine; 2019 Aug; 37(35):5003-5008. PubMed ID: 31301919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
    Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
    Front Immunol; 2022; 13():878832. PubMed ID: 35493458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.
    Ozdil M; Sonmez C; Tugberk Bakar M; Alici Davutoglu E; Madazli R; Kilic S; Vural M; Perk Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():212-216. PubMed ID: 34534737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.
    Fadugba OO; Wang L; Chen Q; Halasa NB
    Clin Vaccine Immunol; 2014 Dec; 21(12):1613-9. PubMed ID: 25253666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.